EUVIMEDEUVIMED entdecken
Open Access

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mateus de Almeida Rainho, Priscyanne Barreto Siqueira, Ísis Salviano Soares de Amorim, Andre Luiz Mencalha, Alessandra Alves Thole

Cancer Drug Resistance · 2023 · 6 (2) · 273-283

DOI: 10.20517/cdr.2022.116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Drug Resistance, 2023. Verfasst von Mateus de Almeida Rainho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Stem Cell Research, Histology and Embryology Department, Roberto Alcantara Gomes Biology Institute, State University of Rio de Janeiro,…. Die Arbeit wurde bisher 28-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the third most diagnosed cancer and the second most deadly type of cancer worldwide. In late diagnosis, CRC can resist therapy regimens in which cancer stem cells (CSCs) are intimately related. CSCs are a subpopulation of tumor cells responsible for tumor initiation and maintenance, metastasis, and resistance to conventional treatments. In this scenario, colorectal cancer stem cells (CCSCs) are considered an important key for therapeutic failure and resistance. In its turn, mitochondria is an organelle involved in many mechanisms in cancer, including chemoresistance of cytotoxic drugs due to alterations in mitochondrial metabolism, apoptosis, dynamics, and mitophagy. Therefore, it is crucial to understand the mitochondrial role in CCSCs regarding CRC drug resistance. It has been shown that enhanced anti-apoptotic protein expression, mitophagy rate, and addiction to oxidative phosphorylation are the major strategies developed by CCSCs to avoid drug insults. Thus, new mitochondria-targeted drug approaches must be explored to mitigate CRC chemoresistance via the ablation of CCSCs.

Schlagwörter

Stichwörter der Autor:innen

Cancer stem cellscolorectal cancerdrug resistancemitochondriamitophagy

Autor:innen und Institutionen

  • Laboratory of Stem Cell Research, Histology and Embryology Department, Roberto Alcantara Gomes Biology Institute, State University of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil.
  • Laboratory of Cancer Biology, Biometry and Biophysics Department, Roberto Alcantara Gomes Biology Institute, State University of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil.

Zitieren

APA

Rainho, M. A., Siqueira, P. B., de Amorim, Í. S. S., Mencalha, A. L., & Thole, A. A. (2023). Mitochondria in colorectal cancer stem cells - a target in drug resistance. Cancer Drug Resistance, 6(2), 273-283. https://doi.org/10.20517/cdr.2022.116

Vancouver

Rainho MA, Siqueira PB, de Amorim ÍSS, Mencalha AL, Thole AA. Mitochondria in colorectal cancer stem cells - a target in drug resistance. Cancer Drug Resistance. 2023;6(2):273-283. doi:10.20517/cdr.2022.116

BibTeX
@article{Rainho2023,
  author = {Rainho, Mateus de Almeida and Siqueira, Priscyanne Barreto and de Amorim, Ísis Salviano Soares and Mencalha, Andre Luiz and Thole, Alessandra Alves},
  title = {Mitochondria in colorectal cancer stem cells - a target in drug resistance},
  journal = {Cancer Drug Resistance},
  year = {2023},
  volume = {6},
  number = {2},
  pages = {273--283},
  doi = {10.20517/cdr.2022.116}
}
Kostenlos starten →